Leading the way to safer medication
 Crosscheck  Recommender


Brand names: ASCOMP WITH CODEINE (in combination) CAFCIT CAFERGOT (in combination) DVORAH (in combination) ESGIC (in combination) FIORICET (in combination) FIORICET WITH CODEINE (in combination) FIORINAL (in combination) FIORINAL WITH CODEINE (in combination) MIGERGOT (in combination) NORGESIC FORTE (in combination) ORPHENGESIC FORTE (in combination) TREZIX (in combination) VANATOL (in combination) VTOL LQ (in combination) ZEBUTAL (in combination)

Therapeutic Indications

Caffeine is indicated for:

Primary apnoea of premature newborns

Irrespective of gender only Newborns (0 - 40 days old)

Cafferine is indicated for the treatment of primary apnoea of premature newborns.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 5-20 mg/kg body weight


Active ingredient Caffeine is contraindicated in the following cases: